Originator Organization TAE Life Sciences LLCStartup |
Active Organization TAE Life Sciences LLCStartup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC9H12BNO5 |
InChIKeyYMMQZZCDVFTFIU-GBSHIBCGSA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Discovery | US | TAE Life Sciences LLCStartup | 20 Oct 2023 |